HER-2 Overexpression Affects TGF-β Responses in Breast Cancer Cells
Author Information
Author(s): Cindy A. Wilson, Elaina E. Cajulis, Jennifer L. Green, Taylor M. Olsen, Young Ah Chung, Michael A. Damore, Judy Dering, Frank J. Calzone, Dennis J. Slamon
Primary Institution: Department of Medicine, David Geffen School of Medicine at UCLA
Hypothesis
Does HER-2 overexpression alter the growth inhibitory effects of TGF-β in breast cancer cells?
Conclusion
HER-2 overexpression promotes breast cancer cell growth by making them resistant to TGF-β's growth inhibitory effects.
Supporting Evidence
- HER-2 overexpression diminishes TGF-β's ability to inhibit cell growth in MCF-7 cells.
- In MDA-MB-231 cells, HER-2 overexpression enhances TGF-β's pro-invasive effects.
- TGF-β signaling is altered in breast cancer cells with high HER-2 expression.
Takeaway
When breast cancer cells have too much HER-2, they don't listen to a signal that usually tells them to stop growing, which can make the cancer worse.
Methodology
Cell proliferation assays, microarray analysis, and various biochemical assays were used to assess the effects of TGF-β on breast cancer cells with different levels of HER-2 expression.
Potential Biases
Potential bias due to the use of engineered cell lines which may not fully mimic in vivo conditions.
Limitations
The study primarily focuses on specific breast cancer cell lines and may not fully represent the complexity of breast cancer in patients.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website